S&P 500   5,253.45 (+0.09%)
DOW   39,787.01 (+0.07%)
QQQ   444.17 (-0.15%)
AAPL   171.33 (-1.14%)
MSFT   420.18 (-0.30%)
META   488.44 (-1.10%)
GOOGL   150.74 (-0.09%)
AMZN   180.47 (+0.36%)
TSLA   177.13 (-1.50%)
NVDA   905.24 (+0.30%)
NIO   4.55 (-2.57%)
AMD   180.92 (+0.74%)
BABA   72.50 (+1.27%)
T   17.67 (+0.68%)
F   13.23 (+1.30%)
MU   117.88 (-1.06%)
CGC   9.05 (-5.24%)
GE   174.97 (-2.86%)
DIS   122.62 (+1.36%)
AMC   3.68 (-15.21%)
PFE   28.05 (+0.97%)
PYPL   67.30 (+1.10%)
XOM   116.07 (+0.96%)
S&P 500   5,253.45 (+0.09%)
DOW   39,787.01 (+0.07%)
QQQ   444.17 (-0.15%)
AAPL   171.33 (-1.14%)
MSFT   420.18 (-0.30%)
META   488.44 (-1.10%)
GOOGL   150.74 (-0.09%)
AMZN   180.47 (+0.36%)
TSLA   177.13 (-1.50%)
NVDA   905.24 (+0.30%)
NIO   4.55 (-2.57%)
AMD   180.92 (+0.74%)
BABA   72.50 (+1.27%)
T   17.67 (+0.68%)
F   13.23 (+1.30%)
MU   117.88 (-1.06%)
CGC   9.05 (-5.24%)
GE   174.97 (-2.86%)
DIS   122.62 (+1.36%)
AMC   3.68 (-15.21%)
PFE   28.05 (+0.97%)
PYPL   67.30 (+1.10%)
XOM   116.07 (+0.96%)
S&P 500   5,253.45 (+0.09%)
DOW   39,787.01 (+0.07%)
QQQ   444.17 (-0.15%)
AAPL   171.33 (-1.14%)
MSFT   420.18 (-0.30%)
META   488.44 (-1.10%)
GOOGL   150.74 (-0.09%)
AMZN   180.47 (+0.36%)
TSLA   177.13 (-1.50%)
NVDA   905.24 (+0.30%)
NIO   4.55 (-2.57%)
AMD   180.92 (+0.74%)
BABA   72.50 (+1.27%)
T   17.67 (+0.68%)
F   13.23 (+1.30%)
MU   117.88 (-1.06%)
CGC   9.05 (-5.24%)
GE   174.97 (-2.86%)
DIS   122.62 (+1.36%)
AMC   3.68 (-15.21%)
PFE   28.05 (+0.97%)
PYPL   67.30 (+1.10%)
XOM   116.07 (+0.96%)
S&P 500   5,253.45 (+0.09%)
DOW   39,787.01 (+0.07%)
QQQ   444.17 (-0.15%)
AAPL   171.33 (-1.14%)
MSFT   420.18 (-0.30%)
META   488.44 (-1.10%)
GOOGL   150.74 (-0.09%)
AMZN   180.47 (+0.36%)
TSLA   177.13 (-1.50%)
NVDA   905.24 (+0.30%)
NIO   4.55 (-2.57%)
AMD   180.92 (+0.74%)
BABA   72.50 (+1.27%)
T   17.67 (+0.68%)
F   13.23 (+1.30%)
MU   117.88 (-1.06%)
CGC   9.05 (-5.24%)
GE   174.97 (-2.86%)
DIS   122.62 (+1.36%)
AMC   3.68 (-15.21%)
PFE   28.05 (+0.97%)
PYPL   67.30 (+1.10%)
XOM   116.07 (+0.96%)
OTCMKTS:SDMHF

Sartorius Stedim Biotech (SDMHF) Stock Price, News & Analysis

$279.50
-9.00 (-3.12%)
(As of 03/27/2024 ET)
Today's Range
$279.50
$279.55
50-Day Range
$240.50
$299.86
52-Week Range
$175.12
$321.11
Volume
25 shs
Average Volume
337 shs
Market Capitalization
N/A
P/E Ratio
64.85
Dividend Yield
0.43%
Price Target
N/A
SDMHF stock logo

About Sartorius Stedim Biotech Stock (OTCMKTS:SDMHF)

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.

SDMHF Stock Price History

SDMHF Stock News Headlines

Sartorius Stedim Biotech SA ADR SRTOY
Sartorius Stedim Biotech S.A. (SDMHF)
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
SARTORIUS (SARTF) Q3 Earnings Lag Estimates
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Preliminary results 2022 of Sartorius Stedim Biotech
Nine-month results 2022 of Sartorius Stedim Biotech
See More Headlines
Receive SDMHF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sartorius Stedim Biotech and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:SDMHF
CIK
N/A
Fax
N/A
Employees
10,662
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Dr. Rene Faber (Age 49)
    CEO & DIrector
    Comp: $590.89k
  • Mr. Rainer Lehmann (Age 49)
    CFO & Member of Executive Board
  • Ms. Petra Muller
    Head of Investor Relations
  • Ms. Petra Kirchhoff (Age 55)
    Head of Corporate Communications & IR
  • Olivier Guitard
    Head of Controlling BPS

SDMHF Stock Analysis - Frequently Asked Questions

Should I buy or sell Sartorius Stedim Biotech stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sartorius Stedim Biotech in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" SDMHF shares.
View SDMHF analyst ratings
or view top-rated stocks.

How have SDMHF shares performed in 2024?

Sartorius Stedim Biotech's stock was trading at $263.75 at the start of the year. Since then, SDMHF stock has increased by 6.0% and is now trading at $279.50.
View the best growth stocks for 2024 here
.

Is Sartorius Stedim Biotech a good dividend stock?

Sartorius Stedim Biotech (OTCMKTS:SDMHF) pays an annual dividend of $1.20 per share and currently has a dividend yield of 0.84%. The dividend payout ratio is 27.84%. This payout ratio is at a healthy, sustainable level, below 75%.

How do I buy shares of Sartorius Stedim Biotech?

Shares of SDMHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:SDMHF) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners